Skip to main content
. Author manuscript; available in PMC: 2016 Dec 28.
Published in final edited form as: Obs Stud. 2016 Feb 1;2:24–38.

Table 2.

Patient characteristics measured using electronic health records in full sample and in sample of survey respondents, unweighted and weighted using inverse probability of response weights to account for measured nonresponse bias.

General Patient Characteristics Full Sample

%
Respondents
Unweighted
%
Respondents
Weighted
%
Age, years 45 to 54 23.0 20.0 22.9
55 to 64 34.8 34.4 34.7
65 to 75 22.1 25.3 22.2
75 and older 20.1 20.2 20.2

Sex Female 61.8 63.2 61.9
Male 38.2 36.8 38.1

Race/ethnicity White non-Hispanic 84.6 85.3 84.5
Other 12.5 12.0 12.6
Unknown 2.9 2.7 2.9

Charlson Score 0 44.2 42.3 44.1
1 8.8 8.9 8.9
2 15.5 17.2 15.6
3 to 5 19.3 20.2 19.4
6 or more 12.1 11.4 12.1

No show appointments
in prior year
0 67.5 67.7 67.5
1 19.6 20.0 19.6
2 or more 12.9 12.3 12.9

Current Smoking No 78.4 80.5 78.5
Yes 21.6 19.5 21.5

Specific Opioid Misuse Risk Factors

Substance Abuse
Diagnosis
No 87.3 87.8 87.3
Yes 12.7 12.2 12.7

Mood/Anxiety disorder
Diagnosis
No 55.8 54.6 55.7
Yes 44.2 45.4 44.3

Hepatitis C/ cirrhosis
Diagnosis
No 93.9 94.6 93.9
Yes 6.1 5.4 6.1

Excess days’ supply of
opioids: prior 2 years
No 91.3 91.1 91.3
Yes 8.7 8.9 8.7

Opioids from 3+ doctors
outside primary care
clinic in prior year
No 89.9 89.7 90.0
Yes 10.1 10.3 10.0

Opioids from emergency
department prescriber
No 89.2 89.0 89.2
Yes 10.8 11.0 10.8

Opioid morphine
equivalent
dose/day
less than 15mg 49.5 49.2 49.4
15mg to less than 50mg 37.4 38.1 37.5
50mg or more 13.1 12.7 13.1

Sedative/hypnotic days’
supply (half-year)
None 55.5 57.1 55.5
1 to 29 days 15.3 14.0 15.2
30 to 89 days 12.6 12.3 12.7
90 or more days 16.6 16.6 16.7